Verocytoxin-producing
Escherichia coli (VTEC), also known as Shiga-toxin producing
E. coli (STEC), is a food-borne zoonotic agent associated with outbreaks worldwide that poses a serious public health concern. Over 380 different VTEC serotypes have been isolated from humans and animals, but only a small number of serotypes are linked to human disease. Serotype O157:H7 is the major source of
E. coli food poisoning outbreaks in the United States (US) (Karmali et al.,
2010). Characteristics of
E. coli serotype O157:H7 (EHEC) infection includes abdominal cramps and bloody diarrhea, as well as the life-threatening complication hemolytic uremic syndrome (HUS) (Karmali et al.,
1983; Karmali,
1989; Griffin and Tauxe,
1991). Karmali and colleagues first identified VTEC as the infectious agent responsible for HUS after correlating
E. coli infection in patients with diarrhea and HUS with the presence of a toxin that produced significant irreversible cytotoxic effects in Vero cells (Konowalchuk et al.,
1977; Karmali et al.,
1985). O'Brien and LaVeck later purified the toxin from an enteropathogenic strain of
E. coli and determined that the toxin was structurally and antigenically similar to the Shiga toxin produced by
Shigella dysenteriae type 1 (O'Brien and LaVeck,
1983).
Shiga toxin is composed of two major subunits, designated A and B (O'Brien et al.,
1992; Paton and Paton,
1998). The B subunit forms a pentamer that binds to globotriaosylceramide-3 (Gb3) (Lingwood et al.,
1987), and this specificity determines where Shiga toxin mediates its pathophysiology. The A subunit exhibits an RNA N-glycosidase activity against the 28S rRNA (Endo et al.,
1988) that inhibits host protein synthesis and induces apotosis (Sandvig,
2001; Karmali et al.,
2010). In humans, EHEC colonizes the large intestine (Phillips et al.,
2000). Shiga toxin released by EHEC binds to endothelial cells expressing Gb3, allowing absorption into the bloodstream and dissemination of the toxin to other organs (Sandvig,
2001). The tissues and cell types expressing Gb3 varies among hosts, and the distribution of Gb3 targets the pathology of toxin-mediated disease to cells expressing Gb3 (Pruimboom-Brees et al.,
2000). For example, renal glomerular endothelium expresses high levels of Gb3 in humans, and Shiga toxin production results in acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia, all typical characteristic of HUS (Karmali et al.,
1983).
Currently no treatment is available for EHEC infections (Goldwater and Bettelheim,
2012). The use of conventional antibiotics exacerbates Shiga toxin-mediated cytotoxicity. In an epidemiology study conducted by the Centers for Disease Control and Prevention, patients treated with antibiotics for EHEC enteritis had a higher risk of developing HUS (Slutsker et al.,
1998). Additional studies support the contraindication of antibiotics in EHEC infection; children on antibiotic therapy for hemorrhagic colitis associated with EHEC had an increased chance of developing HUS (Wong et al.,
2000; Zimmerhackl,
2000; Safdar et al.,
2002; Tarr et al.,
2005). Antibiotics promote Shiga toxin production by enhancing the replication and expression of
stx genes that are encoded within a chromosomally integrated lambdoid prophage genome.
Stx induction also promotes phage-mediated lysis of the EHEC cell envelope, allowing for the release and dissemination of Shiga toxin into the environment (Karch et al.,
1999; Matsushiro et al.,
1999; Wagner et al.,
2002).
Cattle are a major reservoir of EHEC, but unlike in humans, EHEC colonization in adult ruminants is asymptomatic (Cray and Moon,
1995; Brown et al.,
1997; Dean-Nystrom et al.,
1997; Woodward et al.,
1999; Wray et al.,
2000). While humans express Gb3 on their vascular endothelium that promotes much of the pathophysiology associated with Shiga toxin, cattle lack vascular expression of Gb3 (Pruimboom-Brees et al.,
2000). Although Gb3 receptors are detected in the kidney and brain of cattle, Shiga toxin was unable to bind to the blood vessels in the cattle gastrointestinal (GI) tract (Pruimboom-Brees et al.,
2000). As a result, Shiga toxin cannot be endocytosed and transported to other organs to induce vascular damage in cattle. In contrast to humans where EHEC colonizes in the colon and causes electrolyte imbalances, EHEC colonizes the recto-anal junction (RAJ) of cattle where it is impervious to the effects of Shiga toxin (Naylor et al.,
2003). The insensitivity to Shiga toxin and differential preference in colonization sites make cattle a more tolerant host for EHEC and may contribute to persistence and transmission of this human pathogen.
Cattle transmit EHEC to humans by shedding the pathogen in their feces. Fecal shedding may be brief or more extended (Rice et al.,
2003). A proportion of positive animals called “super shedders” excrete more EHEC than others. Although the “super shedders” comprise a small ratio of cattle, it has been estimated that they may be responsible for over 95% of all EHEC bacteria shed (Omisakin et al.,
2003; Chase-Topping et al.,
2007). Evidence supports that high concentrations of EHEC in feces or prolonged shedding may result from intimate colonization at the RAJ (Cobbold et al.,
2007). Once shed into the environment, humans acquire EHEC by consuming contaminated bovine-derived products such as meat, milk, and dairy products (Armstrong et al.,
1996) or contaminated water, unpasteurized apple drinks, and vegetables (Cody et al.,
1999; Hilborn et al.,
1999; Olsen et al.,
2002). Direct contact with ruminants at petting zoos or through interactions with infected people within families, daycare centers, and healthcare institutes represent another source of EHEC transmission (Spika et al.,
1986; Carter et al.,
1987; Rowe et al.,
1993; Rangel et al.,
2005). Bovine manure can harbor viable EHEC for more than seven weeks (Wang et al.,
1996), and the long-term environmental persistence of EHEC poses an increased risk for transmission of EHEC through the fecal-oral route through wash-off to nearby farms or in contaminated grass consumed by other cattle. By gaining a better understanding of how EHEC colonizes the cow, methods can be devised to limit fecal shedding of EHEC into the environment and limit sources of contamination and consequent human infection.